MedWatch

GN denies involvement in false advertising case

GN Hearing acquired US-based online platform Lively after the latter had stopped its misleading marketing, and did therefore not take part in the advertising slipup that led to a settlement in the US including payments to the state of Connecticut. Even so, the mistake won’t be repeated with GN at the helm, it says.

Photo: GN Store Nord / PR

Hearing aid manufacturer GN Hearing is washing its hands of any culpability for a recent misleading marketing blunder in the US, which resulted in settlements between four companies and the Connecticut Office of the Attorney General.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs